A Study of Galcanezumab in Participants With Chronic Cluster Headache
Public ClinicalTrials.gov record NCT02438826. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The main purpose of this study is to evaluate the efficacy of the study drug known as galcanezumab in participants with chronic cluster headache.
Study identification
- NCT ID
- NCT02438826
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 240 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jun 18, 2015 (Actual)
- Primary completion
- Mar 27, 2018 (Actual)
- Completion
- Aug 14, 2019 (Actual)
- Last update posted
- Aug 25, 2020
2015 – 2019
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Mayo Clinic Hospital | Phoenix | Arizona | 85054 | — |
| California Medical Clinic for Headache | Santa Monica | California | 90404 | — |
| Stanford University Hospital | Stanford | California | 94304 | — |
| Colorado Neurological Institute | Englewood | Colorado | 80113 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06510 | — |
| Yale University School of Medicine | New Haven | Connecticut | 06519 | — |
| New England Institute for Clinical Research | Stamford | Connecticut | 06905 | — |
| Mayo Clinic-Jacksonville | Jacksonville | Florida | 32224 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| Michigan Head, Pain and Neurological Institute | Ann Arbor | Michigan | 48104 | — |
| Thomas Jefferson University | Philadelphia | Pennsylvania | 19107 | — |
| Southwestern Medical Center - Dallas | Dallas | Texas | 75390 | — |
| Northwest Clinical Research Center | Bellevue | Washington | 98007-4209 | — |
| West Virginia University Hospital | Morgantown | West Virginia | 26506 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 34 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02438826, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 25, 2020 · Synced Nov 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02438826 live on ClinicalTrials.gov.